Lymphoma Action – championing the patient voice in cell therapyLymphoma Action is the only UK health charity dedicated to people affected by lymphoma. Chief Executive Ropinder Gill Share XLymphoma Action – championing the patient voice in cell therapyhttps://pharmaphorum.com/market-access-2/lymphoma-action-championing-the-patient-voice-in-cell-therapy/
Health Innovators: Owlstone Medical’s Billy Boyle on breath biopsy technologyIn the latest episode of our Health Innovators series, Paul Tunnah speaks to Billy Boyle, co-founder and CEO Share XHealth Innovators: Owlstone Medical’s Billy Boyle on breath biopsy technologyhttps://pharmaphorum.com/video/health-innovators-billy-boyle-owlstone-medical/
A history of Johnson & JohnsonSet up by three brothers back in 1886, Johnson & Johnson continues to keep evolving Share XA history of Johnson & Johnsonhttps://pharmaphorum.com/views-analysis-sales-marketing/a-history-of-johnson-johnson/
Not every cough is COVID – MSD UK’s lung cancer campaignFor World Cancer Day, David Long, business unit director of Oncology at MSD UK tells pharmaphorum about the Share XNot every cough is COVID – MSD UK’s lung cancer campaignhttps://pharmaphorum.com/views-analysis-oncology/world-cancer-day-msd-uk-lung-cancer-campaign/
Why cell therapy manufacture is a team sportLouis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that Share XWhy cell therapy manufacture is a team sporthttps://pharmaphorum.com/market-access-2/why-cell-therapy-manufacture-is-a-team-sport/
2020 in review: Pharma’s progress outside of COVID-19It has been a year dominated by the pandemic and many life sciences research projects were put on Share X2020 in review: Pharma’s progress outside of COVID-19https://pharmaphorum.com/views-analysis-oncology/2020-review-pharmas-progress-outside-of-covid-19/
The top 5 pharma M&A deals of 20202020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout Share XThe top 5 pharma M&A deals of 2020https://pharmaphorum.com/views-and-analysis/the-top-5-pharma-ma-deals-of-2020/
What HCPs think about COVID-19’s impact on cancerCOVID-19’s knock-on effect on cancer patients is of concern by HCPs, with delayed or decreased diagnosis seen as Share XWhat HCPs think about COVID-19’s impact on cancerhttps://pharmaphorum.com/views-analysis-oncology/what-hcps-think-about-covid-19s-impact-on-cancer-diagnosis-and-treatment/
Sharing experiences to level the healthcare playing fieldAmanda Barrell speaks to Alfred Samuels on his experience of prostate cancer and diversifying clinical trials to include Share XSharing experiences to level the healthcare playing fieldhttps://pharmaphorum.com/views-analysis-oncology/sharing-experiences-to-level-the-healthcare-playing-field/
